The Department of Justice has formally asked an appeals court to throw out the Affordable Care Act in its entirety, a drastic change from the Trump administration’s previous stance that only certain provisions of the healthcare law should be tossed.

While many of the largest healthcare companies have seen rising revenues and record profits at the start of 2019, stock prices aren’t reflecting their successes, Axios reported.

House Democrats introduced legislation on April 29 that would delay the implementation of breast cancer screening recommendations first published by the U.S. Preventive Services Task Force (USPSTF) in 2009 for another full year.

With more policymakers proposing, supporting and seriously considering various Medicare-for-all health plans, the Congressional Budget Office took a look at a possible design of such a healthcare system and published a highly anticipated paper.

CMS has finalized a rule to ensure that states cannot divert portions of Medicaid provider payments to third parties beyond what is allowed in the statute.

Aetna’s legal department remains busy. Days after the company settled out of court with a patient who sued for coverage denial in California, it’s in the news in Florida for much the same reason—but with a bigger claimant.

Prostatic artery embolization (PAE) is an effective, minimally invasive treatment option for men with enlarged prostates, according to a new position statement from four interventional radiology societies.

The Society of Interventional Radiology (SIR) and numerous other societies have endorsed prostatic artery embolization (PEA) as a safe and effective method to treat an enlarged prostate in certain patients.